Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?

被引：0
|
作者：
Stefano Di Bella
Milo Gatti
Luigi Principe
机构：
[1] Trieste University,Clinical Department of Medical, Surgical and Health Sciences
[2] University of Bologna,Department of Medical and Surgical Sciences, Alma Mater Studiorum
[3] IRCCS Azienda Ospedaliero-Universitaria di Bologna,Clinical Pharmacology Unit, Department for Integrated Infectious Risk Management
[4] “San Giovanni di Dio” Hospital,Clinical Pathology and Microbiology Unit
来源：
European Journal of Clinical Microbiology & Infectious Diseases | 2023年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 918
页数：1
相关论文
共 50 条
  • [1] Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Di Bella, Stefano
    Gatti, Milo
    Principe, Luigi
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (07) : 917 - 918
  • [2] In Vitro Ceftriaxone Susceptibility in Methicillin-Susceptible Staphylococcus aureus
    Phe, Kady
    Dao, Dorothy
    Palmer, Hannah R.
    Tam, Vincent H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1370 - 1370
  • [3] A case of heparin-induced thrombocytopenia (HIT) triggered by methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
    Sugioka S.
    Doi Y.
    Ishihara T.
    Arisato T.
    Osaki K.
    Koga K.
    Koshikawa M.
    Sugawara A.
    Renal Replacement Therapy, 2 (1)
  • [4] DEVASTATING METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA WITH AN UNKNOWN SOURCE
    Kagita, Navyamani V.
    Thota, Vihitha
    Jain, Akhil
    Ikoro, Udunma N.
    Sheu, Wei-Chun
    Russell, Steven
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S324 - S324
  • [5] Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan
    Shoji, Takayo
    Hirai, Yuji
    Osawa, Makiko
    Totsuka, Kyoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 175 - 180
  • [6] Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
    Davie Wong
    Titus Wong
    Marc Romney
    Victor Leung
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [7] Pharmacodynamics of ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus: is it a viable treatment
    Heffernan, A. J.
    Sime, F. B.
    Lim, S. Mohd Sazlly
    Adiraju, S.
    Wallis, S. C.
    Lipman, J.
    Grant, G. D.
    Roberts, J. A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (03)
  • [8] Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia
    Mohamed, Adham
    Bennett, Nicholas
    Ploetz, Jeannette
    Aragon, Laura
    Kennedy, Kevin
    Boyd, Sarah
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [9] High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Maria Aguado, Jose
    San-Juan, Rafael
    Lalueza, Antonio
    Sanz, Francisca
    Rodriguez-Otero, Joaquin
    Gomez-Gonzalez, Carmen
    Chaves, Fernando
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1099 - 1102
  • [10] Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
    Monogue, Marguerite L.
    Ortwine, Jessica K.
    Wei, Wenjing
    Eljaaly, Khalid
    Bhavan, Kavita P.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 727 - 731
12345